← stocks-llm New chat

Cooper Companies (The) (COO) — insider trading

Health Care

Cooper Companies (The) (COO) has 27 reported SEC Form 4 insider transactions in our data (latest 2026-07-01).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-07-01 Keel Paul A Director Grant / award / vesting (derivative) 2,814 $0.00 $0 Form 4
2026-04-01 Rosebrough Walter M Jr Director Option exercise / conversion (derivative) 832 $0.00 $0 Form 4
2026-04-01 Rosebrough Walter M Jr Director Option exercise / conversion 832 $0.00 $0 Form 4
2026-04-01 Kurzius Lawrence Erik Director Grant / award / vesting (derivative) 3,779 $0.00 $0 Form 4
2026-04-01 Kurzius Lawrence Erik Director Option exercise / conversion (derivative) 3,322 $0.00 $0 Form 4
2026-04-01 Kurzius Lawrence Erik Director Option exercise / conversion 3,322 $0.00 $0 Form 4
2026-04-01 Lucchese Cynthia L Director Grant / award / vesting (derivative) 3,779 $0.00 $0 Form 4
2026-04-01 Lucchese Cynthia L Director Option exercise / conversion (derivative) 3,322 $0.00 $0 Form 4
2026-04-01 Lucchese Cynthia L Director Option exercise / conversion 3,322 $0.00 $0 Form 4
2026-04-01 MADDEN TERESA S Director Grant / award / vesting (derivative) 3,779 $0.00 $0 Form 4
2026-04-01 MADDEN TERESA S Director Option exercise / conversion (derivative) 3,322 $0.00 $0 Form 4
2026-04-01 MADDEN TERESA S Director Option exercise / conversion 3,322 $0.00 $0 Form 4
2026-04-01 Rosebrough Walter M Jr Director Grant / award / vesting (derivative) 3,779 $0.00 $0 Form 4
2026-04-01 Carbone Barbara Director Grant / award / vesting (derivative) 3,779 $0.00 $0 Form 4
2026-04-01 Carbone Barbara Director Option exercise / conversion (derivative) 3,050 $0.00 $0 Form 4
2026-04-01 Carbone Barbara Director Option exercise / conversion 3,050 $0.00 $0 Form 4
2026-04-01 Jay Colleen Director Grant / award / vesting (derivative) 4,157 $0.00 $0 Form 4
2026-04-01 Jay Colleen Director Option exercise / conversion (derivative) 3,322 $0.00 $0 Form 4
2026-04-01 Jay Colleen Director Option exercise / conversion 3,322 $0.00 $0 Form 4
2026-04-01 Rivas Maria Director Grant / award / vesting (derivative) 3,779 $0.00 $0 Form 4
2026-04-01 Rivas Maria Director Option exercise / conversion (derivative) 3,322 $0.00 $0 Form 4
2026-04-01 Rivas Maria Director Option exercise / conversion 3,322 $0.00 $0 Form 4
2026-04-01 WEISS ROBERT S Director Grant / award / vesting (derivative) 3,779 $0.00 $0 Form 4
2026-04-01 WEISS ROBERT S Director Option exercise / conversion (derivative) 3,654 $0.00 $0 Form 4
2026-04-01 WEISS ROBERT S Director Option exercise / conversion 3,654 $0.00 $0 Form 4
2026-01-03 Rosebrough Walter M Jr Director Grant / award / vesting (derivative) 832 $0.00 $0 Form 4
2024-12-10 Andrews Brian G Officer (EVP, CFO & Treasurer) Grant / award / vesting (derivative) 41,563 $0.00 $0 Form 4/A

Ask the chat about COO's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: Cooper Companies (The) (COO).

Last updated 2026-07-01 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.